These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. [Changes of the biohumoral picture in alcoholic hepatopathy treated with thiazolidinecarboxylate of arginine]. Zotti S; Bergamo S; Maddalosso T; Salmi A Arch Sci Med (Torino); 1979; 136(3):363-8. PubMed ID: 44995 [TBL] [Abstract][Full Text] [Related]
50. Correlation between intrasinusoidal neutrophilic infiltration and ceroid-lipofuscinosis in alcoholic liver fibrosis with or without fatty change: clinicopathological comparison with nutritional fatty liver. Kishi M; Maeyama S; Koike J; Aida Y; Yoshida H; Uchikoshi T Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):366A-370A. PubMed ID: 8986240 [TBL] [Abstract][Full Text] [Related]
51. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Rosman AS; Paronetto F; Galvin K; Williams RJ; Lieber CS Arch Intern Med; 1993 Apr; 153(8):965-9. PubMed ID: 7683191 [TBL] [Abstract][Full Text] [Related]
52. [Can toxic alcohol liver parenchyma damage be diagnosed using pathobiochemical parameters?]. Baumgarten R Z Arztl Fortbild (Jena); 1993 Apr; 87(5):365-7. PubMed ID: 8100661 [No Abstract] [Full Text] [Related]
55. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?]. Odegaard S; Busch D Z Gastroenterol; 1989 Feb; 27(2):91-3. PubMed ID: 2658394 [TBL] [Abstract][Full Text] [Related]
56. Intrahepatic gene expression in human alcoholic hepatitis. Seth D; Gorrell MD; Cordoba S; McCaughan GW; Haber PS J Hepatol; 2006 Aug; 45(2):306-20. PubMed ID: 16797773 [TBL] [Abstract][Full Text] [Related]